Literature DB >> 12663490

Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria.

Christopher P Baines1, Chang-Xu Song, Yu-Ting Zheng, Guang-Wu Wang, Jun Zhang, Ou-Li Wang, Yiru Guo, Roberto Bolli, Ernest M Cardwell, Peipei Ping.   

Abstract

Although functional coupling between protein kinase Cepsilon (PKCepsilon) and mitochondria has been implicated in the genesis of cardioprotection, the signal transduction mechanisms that enable this link and the identities of the mitochondrial proteins modulated by PKCepsilon remain unknown. Based on recent evidence that the mitochondrial permeability transition pore may be involved in ischemia/reperfusion injury, we hypothesized that protein-protein interactions between PKCepsilon and mitochondrial pore components may serve as a signaling mechanism to modulate pore function and thus engender cardioprotection. Coimmunoprecipitation and GST-based affinity pull-down from mouse cardiac mitochondria revealed interaction of PKCepsilon with components of the pore, namely voltage-dependent anion channel (VDAC), adenine nucleotide translocase (ANT), and hexokinase II (HKII). VDAC1, ANT1, and HKII were present in the PKCepsilon complex at approximately 2%, approximately 0.2%, and approximately 1% of their total expression, respectively. Moreover, in vitro studies demonstrated that PKCepsilon can directly bind and phosphorylate VDAC1. Incubation of isolated cardiac mitochondria with recombinant PKCepsilon resulted in a significant inhibition of Ca2+-induced mitochondrial swelling, an index of pore opening. Furthermore, cardiac-specific expression of active PKCepsilon in mice, which is cardioprotective, greatly increased interaction of PKCepsilon with the pore components and inhibited Ca2+-induced pore opening. In contrast, cardiac expression of kinase-inactive PKCepsilon did not affect pore opening. Finally, administration of the pore opener atractyloside significantly attenuated the infarct-sparing effect of PKCepsilon transgenesis. Collectively, these data demonstrate that PKCepsilon forms physical interactions with components of the cardiac mitochondrial pore. This in turn inhibits the pathological function of the pore and contributes to PKCepsilon-induced cardioprotection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663490      PMCID: PMC3691672          DOI: 10.1161/01.RES.0000069215.36389.8D

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  36 in total

Review 1.  Signaling--2000 and beyond.

Authors:  T Hunter
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis.

Authors:  John G Pastorino; Nataly Shulga; Jan B Hoek
Journal:  J Biol Chem       Date:  2001-12-18       Impact factor: 5.157

3.  Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis.

Authors:  M Xu; Y Wang; K Hirai; A Ayub; M Ashraf
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-02       Impact factor: 4.733

4.  Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function.

Authors:  R M Fryer; J T Eells; A K Hsu; M M Henry; G J Gross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-01       Impact factor: 4.733

5.  Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation.

Authors:  G W Dorn; M C Souroujon; T Liron; C H Chen; M O Gray; H Z Zhou; M Csukai; G Wu; J N Lorenz; D Mochly-Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection.

Authors:  P Ping; J Zhang; W M Pierce; R Bolli
Journal:  Circ Res       Date:  2001-01-19       Impact factor: 17.367

7.  Hypoxia induces hexokinase II gene expression in human lung cell line A549.

Authors:  S R Riddle; A Ahmad; S Ahmad; S S Deeb; M Malkki; B K Schneider; C B Allen; C W White
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-02       Impact factor: 5.464

Review 8.  Myocardial K(ATP) channels in preconditioning.

Authors:  B O'Rourke
Journal:  Circ Res       Date:  2000-11-10       Impact factor: 17.367

9.  Essential activation of PKC-delta in opioid-initiated cardioprotection.

Authors:  R M Fryer; Y Wang; A K Hsu; G J Gross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-03       Impact factor: 4.733

10.  Molecular conformation dictates signaling module formation: example of PKCepsilon and Src tyrosine kinase.

Authors:  Changxu Song; Thomas M Vondriska; Guang-Wu Wang; Jon B Klein; Xinan Cao; Jun Zhang; Y James Kang; Stanley D'Souza; Peipei Ping
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-03       Impact factor: 4.733

View more
  156 in total

Review 1.  Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning.

Authors:  Michael Zaugg; Marcus C Schaub
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

Review 2.  Heart mitochondria signaling pathways: appraisal of an emerging field.

Authors:  José Marín-García; Michael J Goldenthal
Journal:  J Mol Med (Berl)       Date:  2004-06-23       Impact factor: 4.599

Review 3.  VDAC proteomics: post-translation modifications.

Authors:  Janos Kerner; Kwangwon Lee; Bernard Tandler; Charles L Hoppel
Journal:  Biochim Biophys Acta       Date:  2011-11-19

Review 4.  What can we learn about cardioprotection from the cardiac mitochondrial proteome?

Authors:  Marjan Gucek; Elizabeth Murphy
Journal:  Cardiovasc Res       Date:  2010-08-30       Impact factor: 10.787

5.  Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels.

Authors:  Janet R Manning; Gregory Carpenter; Darius R Porter; Stacey L House; Daniel A Pietras; Thomas Doetschman; Jo el J Schultz
Journal:  Growth Factors       Date:  2012-02-06       Impact factor: 2.511

6.  Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways.

Authors:  Ethan J Anderson; Evelio Rodriguez; Curtis A Anderson; Kathleen Thayne; W Randolph Chitwood; Alan P Kypson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

Review 7.  The molecular composition of the mitochondrial permeability transition pore.

Authors:  Christopher P Baines
Journal:  J Mol Cell Cardiol       Date:  2009-02-20       Impact factor: 5.000

Review 8.  VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation.

Authors:  Diana Fang; Eduardo N Maldonado
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

Review 9.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

Review 10.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.